T. Rowe Price Associates’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386K | Buy |
41,772
+8,733
| +26% | +$80.7K | ﹤0.01% | 2420 |
|
|
2025
Q1 | $284K | Buy |
33,039
+3,842
| +13% | +$33K | ﹤0.01% | 2491 |
|
|
2024
Q4 | $314K | Sell |
29,197
-33,912
| -54% | -$365K | ﹤0.01% | 2481 |
|
|
2024
Q3 | $359K | Buy |
63,109
+9,314
| +17% | +$53K | ﹤0.01% | 2398 |
|
|
2024
Q2 | $228K | Buy |
53,795
+2,021
| +4% | +$8.57K | ﹤0.01% | 2541 |
|
|
2024
Q1 | $264K | Buy |
51,774
+946
| +2% | +$4.82K | ﹤0.01% | 2490 |
|
|
2023
Q4 | $474K | Buy |
50,828
+1,319
| +3% | +$12.3K | ﹤0.01% | 2194 |
|
|
2023
Q3 | $325K | Buy |
49,509
+6,140
| +14% | +$40.3K | ﹤0.01% | 2295 |
|
|
2023
Q2 | $353K | Buy |
43,369
+875
| +2% | +$7.12K | ﹤0.01% | 2282 |
|
|
2023
Q1 | $365K | Buy |
42,494
+427
| +1% | +$3.67K | ﹤0.01% | 2249 |
|
|
2022
Q4 | $390K | Buy |
42,067
+626
| +2% | +$5.8K | ﹤0.01% | 2259 |
|
|
2022
Q3 | $428K | Buy |
41,441
+4,480
| +12% | +$46.3K | ﹤0.01% | 2200 |
|
|
2022
Q2 | $370K | Buy |
36,961
+509
| +1% | +$5.1K | ﹤0.01% | 2343 |
|
|
2022
Q1 | $449K | Buy |
36,452
+4,747
| +15% | +$58.5K | ﹤0.01% | 2379 |
|
|
2021
Q4 | $550K | Buy |
31,705
+664
| +2% | +$11.5K | ﹤0.01% | 2341 |
|
|
2021
Q3 | $557K | Buy |
31,041
+9,900
| +47% | +$178K | ﹤0.01% | 2329 |
|
|
2021
Q2 | $483K | Sell |
21,141
-501
| -2% | -$11.4K | ﹤0.01% | 2398 |
|
|
2021
Q1 | $324K | Sell |
21,642
-44,350
| -67% | -$664K | ﹤0.01% | 2534 |
|
|
2020
Q4 | $356K | Sell |
65,992
-24,100
| -27% | -$130K | ﹤0.01% | 2366 |
|
|
2020
Q3 | $410K | Sell |
90,092
-70
| -0.1% | -$319 | ﹤0.01% | 2173 |
|
|
2020
Q2 | $444K | Sell |
90,162
-24,714
| -22% | -$122K | ﹤0.01% | 2092 |
|
|
2020
Q1 | $362K | Buy |
114,876
+84,700
| +281% | +$267K | ﹤0.01% | 2125 |
|
|
2019
Q4 | $78K | Buy |
30,176
+1,701
| +6% | +$4.4K | ﹤0.01% | 2466 |
|
|
2019
Q3 | $90K | Buy |
28,475
+196
| +0.7% | +$619 | ﹤0.01% | 2450 |
|
|
2019
Q2 | $95K | Buy |
28,279
+810
| +3% | +$2.72K | ﹤0.01% | 2477 |
|
|
2019
Q1 | $84K | Buy |
27,469
+741
| +3% | +$2.27K | ﹤0.01% | 2475 |
|
|
2018
Q4 | $42K | Sell |
26,728
-29,200
| -52% | -$45.9K | ﹤0.01% | 2520 |
|
|
2018
Q3 | $153K | Buy |
55,928
+271
| +0.5% | +$741 | ﹤0.01% | 2483 |
|
|
2018
Q2 | $146K | Buy |
55,657
+50
| +0.1% | +$131 | ﹤0.01% | 2486 |
|
|
2018
Q1 | $153K | Buy |
55,607
+373
| +0.7% | +$1.03K | ﹤0.01% | 2437 |
|
|
2017
Q4 | $178K | Buy |
55,234
+1,086
| +2% | +$3.5K | ﹤0.01% | 2425 |
|
|
2017
Q3 | $224K | Buy |
54,148
+626
| +1% | +$2.59K | ﹤0.01% | 2359 |
|
|
2017
Q2 | $285K | Buy |
53,522
+237
| +0.4% | +$1.26K | ﹤0.01% | 2259 |
|
|
2017
Q1 | $306K | Buy |
53,285
+23,500
| +79% | +$135K | ﹤0.01% | 2253 |
|
|
2016
Q4 | $118K | Hold |
29,785
| – | – | ﹤0.01% | 2454 |
|
|
2016
Q3 | $108K | Buy |
+29,785
| New | +$108K | ﹤0.01% | 2435 |
|